Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
17.48
+0.06 (0.34%)
At close: May 30, 2025, 4:00 PM
17.80
+0.32 (1.83%)
After-hours: May 30, 2025, 5:38 PM EDT
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Sabra Health Care REIT stock ranges from a low of $18 to a high of $20. The average analyst price target of $19.57 forecasts a 11.96% increase in the stock price over the next year.
Price Target: $19.57 (+11.96%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 1 | 1 | 1 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +8.70% | May 12, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | +2.97% | Mar 18, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $20 | Buy | Reiterates | $20 | +14.42% | Feb 21, 2025 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $18 → $17 | Strong Buy → Hold | Downgrades | $18 → $17 | -2.75% | Jan 17, 2025 |
| JMP Securities | JMP Securities | Hold → Buy Upgrades $20 | Hold → Buy | Upgrades | $20 | +14.42% | Jan 7, 2025 |
Financial Forecast
Revenue This Year
744.81M
from 702.64M
Increased by 6.00%
Revenue Next Year
782.82M
from 744.81M
Increased by 5.10%
EPS This Year
0.72
from 0.54
Increased by 33.57%
EPS Next Year
0.79
from 0.72
Increased by 9.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 792.7M | 843.5M | 901.7M | ||
| Avg | 744.8M | 782.8M | 808.4M | ||
| Low | 690.4M | 706.3M | 722.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.8% | 13.2% | 15.2% | ||
| Avg | 6.0% | 5.1% | 3.3% | ||
| Low | -1.7% | -5.2% | -7.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.80 | 0.88 | 0.86 |
| Avg | 0.72 | 0.79 | 0.82 |
| Low | 0.67 | 0.72 | 0.77 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 47.8% | 22.3% | 8.6% |
| Avg | 33.6% | 9.9% | 3.6% |
| Low | 23.4% | -0.8% | -2.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.